P_change	Gene	Transcript	Disease	Drug	Level
762_823ins	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	R1
T790M	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	R1
Oncogenic Mutations	KRAS	ENST00000256078	Colorectal Cancer	Panitumumab, Cetuximab	R1
Oncogenic Mutations	NRAS	ENST00000369535	Colorectal Cancer	Panitumumab, Cetuximab	R1
D842V	PDGFRA	ENST00000257290	Gastrointestinal Stromal Tumor	Imatinib	R1
BCR-ABL1 Fusion	ABL1	ENST00000318560	B-Lymphoblastic Leukemia/Lymphoma	Dasatinib, Imatinib	1
BCR-ABL1 Fusion	ABL1	ENST00000318560	Chronic Myelogenous Leukemia	Nilotinib, Dasatinib, Imatinib	1
Fusions	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Crizotinib, Brigatinib, Alectinib, Ceritinib	1
V600E	BRAF	ENST00000288602	Anaplastic Thyroid Cancer	Dabrafenib + Trametinib	1
V600	BRAF	ENST00000288602	Erdheim-Chester Disease	Vemurafenib	1
V600E	BRAF	ENST00000288602	Melanoma	Vemurafenib, Dabrafenib, Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib, Encorafenib + Binimetinib	1
V600K	BRAF	ENST00000288602	Melanoma	Dabrafenib + Trametinib, Vemurafenib + Cobimetinib, Trametinib, Encorafenib + Binimetinib	1
V600E	BRAF	ENST00000288602	Non-Small Cell Lung Cancer	Dabrafenib + Trametinib	1
Oncogenic Mutations	BRCA1	ENST00000357654	Ovarian Cancer	Rucaparib, Niraparib	1
Oncogenic Mutations	BRCA2	ENST00000380152	Ovarian Cancer	Rucaparib, Niraparib	1
A750P	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
A763_Y764insFQEA	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
E709K	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
E709_T710delinsD	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	1
729_761del	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib	1
729_761indel	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib	1
729_761ins	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	1
G719	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
Kinase Domain Duplication	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	1
L747P	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	1
L833V	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Afatinib, Erlotinib, Gefitinib	1
L858R	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Osimertinib, Dacomitinib, Gefitinib	1
L861	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
M277E	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
S768I	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Erlotinib, Afatinib, Gefitinib	1
T790M	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Osimertinib	1
Amplification	ERBB2	ENST00000269571	Breast Cancer	Lapatinib + Trastuzumab, Pertuzumab + Trastuzumab, Ado-Trastuzumab Emtansine, Lapatinib, Neratinib, Trastuzumab	1
Amplification	ERBB2	ENST00000269571	Esophagogastric Cancer	Trastuzumab	1
Oncogenic Mutations	IDH1	ENST00000345146	Acute Myeloid Leukemia	Ivosidenib	1
R140Q	IDH2	ENST00000330062	Acute Myeloid Leukemia	Enasidenib	1
R172	IDH2	ENST00000330062	Acute Myeloid Leukemia	Enasidenib	1
C788_N828mut	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Regorafenib	1
Oncogenic Mutations	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Regorafenib, Imatinib, Sunitinib	1
T670I	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Regorafenib, Sunitinib	1
V654A	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Regorafenib, Sunitinib	1
Wildtype	KRAS	ENST00000256078	Colorectal Cancer	Regorafenib, Panitumumab, Cetuximab	1
Fusions	NTRK1	ENST00000524377	All Solid Tumors	Larotrectinib	1
Fusions	NTRK2	ENST00000277120	All Solid Tumors	Larotrectinib	1
Fusions	NTRK3	ENST00000360948	All Solid Tumors	Larotrectinib	1
MSI-H	Other Biomarkers	null	All Solid Tumors	Pembrolizumab	1
MSI-H	Other Biomarkers	null	Colorectal Cancer	Nivolumab	1
FIP1L1-PDGFRA Fusion	PDGFRA	ENST00000257290	Chronic Eosinophilic Leukemia, NOS	Imatinib	1
Fusions	PDGFRA	ENST00000257290	Myelodysplastic/Myeloproliferative Neoplasms	Imatinib	1
Fusions	PDGFRB	ENST00000261799	Dermatofibrosarcoma Protuberans	Imatinib	1
Fusions	PDGFRB	ENST00000261799	Myelodysplastic/Myeloproliferative Neoplasms	Imatinib	1
Fusions	ROS1	ENST00000368508	Non-Small Cell Lung Cancer	Crizotinib	1
Oncogenic Mutations	TSC1	ENST00000298552	CNS Cancer	Everolimus	1
Oncogenic Mutations	TSC2	ENST00000219476	CNS Cancer	Everolimus	1
Fusions	ALK	ENST00000389048	Inflammatory Myofibroblastic Tumor	Crizotinib, Ceritinib	2A
Oncogenic Mutations	BRCA1	ENST00000357654	Breast Cancer	Talazoparib, Olaparib	2A
Oncogenic Mutations	BRCA1	ENST00000357654	Ovarian Cancer	Olaparib	2A
Oncogenic Mutations	BRCA2	ENST00000380152	Breast Cancer	Talazoparib, Olaparib	2A
Oncogenic Mutations	BRCA2	ENST00000380152	Ovarian Cancer	Olaparib	2A
Amplification	CDK4	ENST00000257904	Dedifferentiated Liposarcoma	Abemaciclib, Palbociclib	2A
Amplification	CDK4	ENST00000257904	Well-Differentiated Liposarcoma	Abemaciclib, Palbociclib	2A
C788_N828mut	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Sorafenib	2A
D816	KIT	ENST00000288135	Melanoma	Imatinib	2A
C788_N828mut	KIT	ENST00000288135	Melanoma	Imatinib	2A
Oncogenic Mutations	KIT	ENST00000288135	Melanoma	Imatinib	2A
T670I	KIT	ENST00000288135	Melanoma	Imatinib	2A
V654A	KIT	ENST00000288135	Melanoma	Imatinib	2A
D816	KIT	ENST00000288135	Thymic Tumor	Sunitinib, Sorafenib	2A
C788_N828mut	KIT	ENST00000288135	Thymic Tumor	Sunitinib, Sorafenib	2A
Oncogenic Mutations	KIT	ENST00000288135	Thymic Tumor	Sunitinib, Sorafenib	2A
T670I	KIT	ENST00000288135	Thymic Tumor	Sunitinib, Sorafenib	2A
V654A	KIT	ENST00000288135	Thymic Tumor	Sunitinib, Sorafenib	2A
Amplification	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
D1010H	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
D1010N	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
D1010Y	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
963_1028splice	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
Y1003C	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
Y1003F	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
Y1003N	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib	2A
Amplification	MET	ENST00000397752	Renal Cell Carcinoma	Cabozantinib	2A
D842V	PDGFRA	ENST00000257290	Gastrointestinal Stromal Tumor	Dasatinib	2A
Oncogenic Mutations	PDGFRA	ENST00000257290	Gastrointestinal Stromal Tumor	Imatinib	2A
Fusions	RET	ENST00000355710	Non-Small Cell Lung Cancer	Cabozantinib, Vandetanib, LOXO-292, BLU-667	2A
Oncogenic Mutations	TSC1	ENST00000298552	Renal Cell Carcinoma	Everolimus	2A
Oncogenic Mutations	TSC2	ENST00000219476	Renal Cell Carcinoma	Everolimus	2A
E17K	AKT1	ENST00000349310	Breast Cancer	AZD5363	3A
E17K	AKT1	ENST00000349310	Endometrial Cancer	AZD5363	3A
E17K	AKT1	ENST00000349310	Ovarian Cancer	AZD5363	3A
G1202R	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Lorlatinib	3A
Oncogenic Mutations	ARAF	ENST00000377045	Histiocytosis	Sorafenib	3A
Oncogenic Mutations	ARAF	ENST00000377045	Non-Small Cell Lung Cancer	Sorafenib	3A
V600	BRAF	ENST00000288602	Colorectal Cancer	Panitumumab + Dabrafenib + Trametinib	3A
V600E	BRAF	ENST00000288602	Colorectal Cancer	Encorafenib + Binimetinib + Cetuximab	3A
Fusions	BRAF	ENST00000288602	Melanoma	Cobimetinib, Trametinib	3A
K601	BRAF	ENST00000288602	Melanoma	Trametinib	3A
L597	BRAF	ENST00000288602	Melanoma	Trametinib	3A
Fusions	BRAF	ENST00000288602	Ovarian Cancer	Cobimetinib, Trametinib	3A
762_823ins	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Poziotinib	3A
Oncogenic Mutations	ERBB2	ENST00000269571	Breast Cancer	Neratinib	3A
Oncogenic Mutations	ERBB2	ENST00000269571	Non-Small Cell Lung Cancer	Ado-Trastuzumab Emtansine, Neratinib	3A
Oncogenic Mutations	ERCC2	ENST00000391945	Bladder Cancer	Cisplatin	3A
Oncogenic Mutations	ESR1	ENST00000206249	Breast Cancer	AZD9496, Fulvestrant	3A
Amplification	FGFR1	ENST00000425967	Lung Squamous Cell Carcinoma	AZD4547, BGJ398, Erdafitinib, Debio1347	3A
Fusions	FGFR2	ENST00000358487	Bladder Cancer	AZD4547, BGJ398, Erdafitinib, Debio1347	3A
Fusions	FGFR2	ENST00000358487	Cholangiocarcinoma	AZD4547, BGJ398, Erdafitinib, Debio1347	3A
Fusions	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
G370C	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
G380R	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
K650	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
R248C	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
S249C	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
S371C	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
Y373C	FGFR3	ENST00000260795	Bladder Cancer	AZD4547, Erdafitinib, BGJ398, Debio1347	3A
Internal tandem duplication	FLT3	ENST00000241453	Acute Myeloid Leukemia	Sorafenib	3A
Oncogenic Mutations	HRAS	ENST00000311189	Head and Neck Squamous Cell Carcinoma	Tipifarnib	3A
PCM1-JAK2 Fusion	JAK2	ENST00000381652	Chronic Eosinophilic Leukemia, NOS	Ruxolitinib	3A
D816	KIT	ENST00000288135	Mastocytosis	Avapritinib	3A
Oncogenic Mutations	MAP2K1	ENST00000307102	Histiocytosis	Cobimetinib, Trametinib	3A
Oncogenic Mutations	MAP2K1	ENST00000307102	Low-Grade Serous Ovarian Cancer	Cobimetinib, Trametinib	3A
Oncogenic Mutations	MAP2K1	ENST00000307102	Melanoma	Cobimetinib, Trametinib	3A
Oncogenic Mutations	MAP2K1	ENST00000307102	Non-Small Cell Lung Cancer	Cobimetinib, Trametinib	3A
Amplification	MDM2	ENST00000462284	Liposarcoma	DS-3032b, RG7112	3A
D1010H	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
D1010N	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
D1010Y	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
963_1028splice	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
Y1003C	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
Y1003F	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
Y1003N	MET	ENST00000397752	Non-Small Cell Lung Cancer	Cabozantinib, Capmatinib	3A
E2014K	MTOR	ENST00000361445	Bladder Cancer	Everolimus	3A
E2419K	MTOR	ENST00000361445	Bladder Cancer	Everolimus	3A
L1460P	MTOR	ENST00000361445	Renal Cell Carcinoma	Temsirolimus	3A
L2209V	MTOR	ENST00000361445	Renal Cell Carcinoma	Temsirolimus	3A
L2427Q	MTOR	ENST00000361445	Renal Cell Carcinoma	Temsirolimus	3A
Q2223K	MTOR	ENST00000361445	Renal Cell Carcinoma	Everolimus	3A
Oncogenic Mutations	NRAS	ENST00000369535	Melanoma	Binimetinib, Binimetinib + Ribociclib	3A
Oncogenic Mutations	NRAS	ENST00000369535	Thyroid Cancer	Selumetinib + Radioiodine Uptake Therapy	3A
Fusions	NTRK1	ENST00000524377	All Solid Tumors	Entrectinib	3A
Fusions	NTRK2	ENST00000277120	All Solid Tumors	Entrectinib	3A
Fusions	NTRK3	ENST00000360948	All Solid Tumors	Entrectinib	3A
Oncogenic Mutations	PIK3CA	ENST00000263967	Breast Cancer	Buparlisib, Alpelisib + Fulvestrant, Serabelisib, Copanlisib, GDC-0077, Taselisib + Fulvestrant, Alpelisib, Buparlisib + Fulvestrant, Taselisib	3A
Truncating Mutations	PTCH1	ENST00000331920	Embryonal Tumor	Sonidegib	3A
Truncating Mutations	PTCH1	ENST00000331920	Skin Cancer, Non-Melanoma	Sonidegib, Vismodegib	3A
Oncogenic Mutations	RET	ENST00000355710	Medullary Thyroid Cancer	LOXO-292, BLU-667	3A
C1156Y	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Lorlatinib	4
G1269A	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Lorlatinib	4
I1171N	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Lorlatinib	4
L1196M	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Lorlatinib	4
Oncogenic Mutations	ATM	ENST00000278616	All Solid Tumors	Olaparib	4
D287H	BRAF	ENST00000288602	All Tumors	PLX8394	4
D594	BRAF	ENST00000288602	All Tumors	PLX8394	4
F595L	BRAF	ENST00000288602	All Tumors	PLX8394	4
G464	BRAF	ENST00000288602	All Tumors	PLX8394	4
G466	BRAF	ENST00000288602	All Tumors	PLX8394	4
G469	BRAF	ENST00000288602	All Tumors	PLX8394	4
G596	BRAF	ENST00000288602	All Tumors	PLX8394	4
K601	BRAF	ENST00000288602	All Tumors	PLX8394	4
L597	BRAF	ENST00000288602	All Tumors	PLX8394	4
N581	BRAF	ENST00000288602	All Tumors	PLX8394	4
S467L	BRAF	ENST00000288602	All Tumors	PLX8394	4
V459L	BRAF	ENST00000288602	All Tumors	PLX8394	4
Oncogenic Mutations	CDKN2A	ENST00000304494	All Solid Tumors	Abemaciclib, Palbociclib, Ribociclib	4
A289V	EGFR	ENST00000275493	Glioma	Lapatinib	4
Amplification	EGFR	ENST00000275493	Glioma	Lapatinib	4
R108K	EGFR	ENST00000275493	Glioma	Lapatinib	4
T263P	EGFR	ENST00000275493	Glioma	Lapatinib	4
D761Y	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Osimertinib	4
EWSR1-FLI1 Fusion	EWSR1	ENST00000397938	Ewing Sarcoma	TK216	4
Oncogenic Mutations	FGFR1	ENST00000425967	All Solid Tumors	AZD4547, BGJ398, Erdafitinib, Debio1347	4
Oncogenic Mutations	FGFR2	ENST00000358487	All Solid Tumors	AZD4547, BGJ398, Erdafitinib, Debio1347	4
Oncogenic Mutations	FGFR3	ENST00000260795	All Solid Tumors	AZD4547, BGJ398, Erdafitinib, Debio1347	4
Oncogenic Mutations	KDM6A	ENST00000377967	Bladder Cancer	Tazemetostat, GSK343	4
Oncogenic Mutations	KRAS	ENST00000256078	All Tumors	Cobimetinib, Binimetinib, Trametinib	4
Oncogenic Mutations	MTOR	ENST00000361445	All Solid Tumors	Temsirolimus, Everolimus	4
Oncogenic Mutations	NF1	ENST00000358273	All Solid Tumors	Cobimetinib, Trametinib	4
Oncogenic Mutations	PTEN	ENST00000371953	All Tumors	GSK2636771, AZD8186	4
Oncogenic Mutations	SMARCB1	ENST00000263121	All Tumors	Tazemetostat	4
C1156Y	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Crizotinib	R2
G1202R	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Alectinib	R2
G1269A	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Crizotinib	R2
I1171N	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Alectinib	R2
L1196M	ALK	ENST00000389048	Non-Small Cell Lung Cancer	Crizotinib	R2
C797G	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Osimertinib	R2
C797S	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Osimertinib	R2
D761Y	EGFR	ENST00000275493	Non-Small Cell Lung Cancer	Gefitinib	R2
C788_N828mut	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Imatinib, Sunitinib	R2
T670I	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Imatinib	R2
V654A	KIT	ENST00000288135	Gastrointestinal Stromal Tumor	Imatinib	R2
Amplification	MET	ENST00000397752	Non-Small Cell Lung Cancer	Erlotinib, Gefitinib	R2
D1228N	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib, Cabozantinib, Capmatinib	R2
Y1230H	MET	ENST00000397752	Non-Small Cell Lung Cancer	Crizotinib, Capmatinib	R2
G595R	NTRK1	ENST00000524377	All Solid Tumors	Larotrectinib	R2
G623R	NTRK3	ENST00000360948	All Solid Tumors	Larotrectinib	R2
